Drug
Cd73 Antigen
Cd73 Antigen: highest development phase Phase 1, developed by BioNTech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BioNTech
Trials
| Drug | Phase | Indication |
|---|---|---|
| CD73 Antigen NCT05950815 | Phase 1 | Advanced Solid Tumor |
Latest
No recent events.
Follow Cd73 Antigen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.